XML 14 R4.htm IDEA: XBRL DOCUMENT v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating expenses    
Research and development $ 5,814 $ 16,157
General and administrative 5,138 5,645
Total operating expenses 10,952 21,802
Loss from operations (10,952) (21,802)
Interest income 164 624
Change in fair value of warrant liability 9,640
Other expense, net (26) (63)
Total other income, net 9,778 561
Net loss and comprehensive loss $ (1,174) $ (21,241)
Net loss per share attributable to common stockholders, basic (in Dollars per share) $ (0.04) $ (1.41)
Net loss per share attributable to common stockholders, diluted (in Dollars per share) $ (0.04) $ (1.41)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in Shares) 28,671,819 15,022,122
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in Shares) 28,671,819 15,022,122